Newbridge Financial Services Group’s BioVie BIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-140
Closed -$266 1217
2025
Q3
$266 Hold
140
﹤0.01% 1241
2025
Q2
$1.29K Hold
140
﹤0.01% 1176
2025
Q1
$1.37K Hold
140
﹤0.01% 922
2024
Q4
$2.8K Hold
140
﹤0.01% 934
2024
Q3
$1.68K Hold
140
﹤0.01% 575
2024
Q2
$5.61K Sell
140
-30
-18% -$1.44K ﹤0.01% 825
2024
Q1
$8.99K Buy
170
+110
+183% +$11.3K ﹤0.01% 795
2023
Q4
$7.56K Buy
60
+50
+500% +$15K ﹤0.01% 796
2023
Q3
$3.41K Hold
10
﹤0.01% 1010
2023
Q2
$4.31K Hold
10
﹤0.01% 1033
2023
Q1
$8.08K Hold
10
﹤0.01% 960
2022
Q4
$7.77K Buy
+10
New +$5.41K ﹤0.01% 968

Other funds holding BIVI

Newbridge Financial Services Group's BIVI Position: Q4 2025 in Review

Newbridge Financial Services Group sold out of BioVie (BIVI) in Q4 2025, closing a stake of 140 shares — an estimated $266 sold.

Newbridge Financial Services Group first reported a position in BIVI in Q4 2022 and held it in 12 quarters. The position peaked at $8.99K in Q1 2024. 35 funds tracked by Wall St. Rank hold BIVI as of Q4 2025.

  • Newbridge Financial Services Group reported no remaining BioVie position as of Q4 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 140 BioVie shares in Q4 2025, an estimated $266.
  • Newbridge Financial Services Group first reported a position in BioVie in Q4 2022 and held it in 12 quarters.
  • Newbridge Financial Services Group's BioVie position peaked at $8.99K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held BioVie as of Q4 2025.

Based on Newbridge Financial Services Group's 13F filing for Q4 2025, filed 21 Jan 2026.